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Metabolic syndrome and diabetes impact brain function and metabolism. While it is well
established that rodents exposed to diets rich in saturated fat develop brain dysfunction,
contrasting results abound in the literature, likely as result of exposure to different
high-fat diet (HFD) compositions and for varied periods of time. In the present study,
we investigated alterations of hippocampal-dependent spatial memory by measuring
Y-maze spontaneous alternation, metabolic profiles of the hippocampus, cortex and
hypothalamus by 1H magnetic resonance spectroscopy (MRS), and levels of proteins
specific to synaptic and glial compartments in mice exposed for 6 months to different
amounts of fat (10, 45, or 60% of total energy intake). Increasing the dietary amount
of fat from 10 to 45% or 60% resulted in obesity accompanied by increased leptin,
fasting blood glucose and insulin, and reduced glucose tolerance. In comparison to
controls (10%-fat), only mice fed the 60%-fat diet showed increased fed glycemia,
as well as plasma corticosterone that has a major impact on brain function. HFD-
induced metabolic profile modifications measured by 1H MRS were observed across
the three brain areas in mice exposed to 60%- but not 45%-fat diet, while both
HFD groups displayed impaired hippocampal-dependent memory. HFD also affected
systems involved in neuro- or gliotransmission in the hippocampus. Namely, relative
to controls, 60%-fat-fed mice showed reduced SNAP-25, PSD-95 and syntaxin-4
immunoreactivity, while 45%-fat-fed mice showed reduced gephyrin and syntaxin-4
immunoreactivity. For both HFD levels, reductions of the vesicular glutamate transporter
vGlut1 and levels of the vesicular GABA transporter were observed in the hippocampus
and hypothalamus, relative to controls. Immunoreactivity against GFAP and/or Iba-1
in the hypothalamus was higher in mice exposed to HFD than controls, suggesting
occurrence of gliosis. We conclude that different levels of dietary fat result in distinct
neurochemical alterations in the brain.
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INTRODUCTION
The ever-increasing life expectancy has led to a dramatic increase
in the prevalence of age-associated disorders namely metabolic
syndrome and type 2 diabetes (T2D), and neurodegenerative
disorders, such as Alzheimer’s disease (AD). Notably, there
is a growing body of epidemiological evidence suggesting
that both metabolic syndrome and T2D increase the risk
of developing age-related cognitive decline, mild cognitive
impairment, vascular dementia, and AD (Frisardi et al., 2010;
Duarte, 2015).
In addition to the many components of metabolic syndrome
that may affect brain function, brain insulin resistance is a
proposed mechanistic link between T2D and AD. Indeed, post-
mortem analyses of brains from dementia patients revealed
that insulin receptors are downregulated, and pointed toward
a major role of neuronal insulin resistance in the etiology of
AD (Steculorum et al., 2014; Duarte, 2015). Insulin receptors
are widely distributed in the brain (Havrankova et al., 1978;
Hill et al., 1986). Insulin and insulin-like growth factor 1
(IGF-1), which have converging signaling pathways in the
brain, regulate the neuronal control of energy and glucose
homeostasis by acting on hypothalamic nuclei (Steculorum et al.,
2014), and also regulate cognitive processes through its actions
on neurotransmission, synaptic plasticity, and neurogenesis
within cortical and hippocampal circuits (Fernandez and Torres-
Alemán, 2012).
A number of components of the metabolic syndrome such as
hyperglycemia, microvascular complications, insulin resistance,
dyslipidemia and hypertension occur in diabetes, and are risk
factors for cognitive dysfunction (Duarte, 2015; Moheet et al.,
2015). Although this combination of factors with potential
impact on the central nervous system makes the mechanisms
of diabetes-induced brain dysfunction difficult to study, research
on different rodent models of diabetes have found that diabetic
conditions lead to synaptic deterioration that results in defective
neurotransmission and synaptic plasticity (Duarte et al., 2009,
2012a; Calvo-Ochoa et al., 2014), as well as neuroinflammation
and astrogliosis (Saravia et al., 2002; Baydas et al., 2003; Duarte
et al., 2009, 2012a; Calvo-Ochoa et al., 2014).
Changes in the cellular integrity of neurons and astrocytes
are likely reflected on brain metabolic regulation, as well as
metabolic profiles. Indeed, studies employing MRS, which allow
to quantify brain metabolite profiles in a non-invasive manner,
have generally identified reduced levels of the putative neuronal
marker N-acetylaspartate, as well as increased in myo-inositol
content (a proposed marker of astrocyte density) in brains
of subjects with both AD and diabetes, relative to healthy
individuals (reviewed in Duarte, 2016). Accordingly, altered
metabolite profiles have been also reported in the brain of
diabetes and HFD-induced obesity models (van der Graaf et al.,
Abbreviations: Aβ, amyloid β; AD, Alzheimer’s disease; ANOVA, analysis of
variance; CRLB, Cramér-Rao lower bound; GABA, γ-aminobutyrate; HFD, high-
fat diet; IGF-1, insulin-like growth factor 1; LSD, least significant difference; MOPS,
3-(N-morpholino)propanesulfonic acid; MRS, magnetic resonance spectroscopy;
NAAG, N-acetylaspartylglutamate; TBS, Tris-buffered saline; T2D, type 2 diabetes;
VOI, volume of interest.
2004; Duarte et al., 2009; Wang et al., 2012; Lizarbe et al., 2018;
Ribeiro et al., 2018).
In the present study, we tested the hypothesis that the
severity of the metabolic syndrome is related to the degree of
neurochemical alterations, as well as brain function deficits. For
that, mice were fed diets containing different amounts of fat
during 6 months, which lead to different degrees of glucose
intolerance and insulin resistance (Soares et al., 2018). We then
evaluated spatial memory performance, metabolic profiles of the
hippocampus, cortex and hypothalamus, and levels of proteins
specific to synaptic and glial compartments.
MATERIALS AND METHODS
Animals
Animal experiments were performed with the approval by
the local ethics committee (Service de la Consommation et
des Affaires Vétérinaires, Epalinges, Switzerland). Sample size
estimation was based on previous MRS experiments (Gapp et al.,
2017; Lizarbe et al., 2018). Eleven-week-old male C57BL/6J
mice were purchased from Charles River (L’Arbresle, France),
and housed in groups of 3–4 on a 12-h light-dark cycle
with lights on at 07:00, room temperature at 21–23◦C, and
humidity at 55–60%. Mice were randomly split in three
groups (n = 11/group), and dietary interventions started after
1 week of acclimatization to the facility, i.e., at 3 months
of age. During 6 months, mice were fed standardized diets
containing 10%, 45%, or 60% of kilocalories from lard-
based fat (D12450B, D12451, D12492, Research Diets, New
Brunswick, NJ, United States), as previously detailed (Soares
et al., 2018). Food and tap water were provided ad libitum.
After this 6-month housing period, the following procedures
were carried out sequentially with 2 days of interval: behavior
experiments, one MRS scan session, glucose tolerance tests, tissue
collection.
Behavioral Tasks
Exploratory behavior and locomotor activity of mice was
evaluated over a 5-min period in the dark, using a squared open
field arena measuring 30 cm× 30 cm and 25 cm high, divided in
four squares of 15 cm× 15 cm. The number of crossings in these
squares and the number of rearing movements with forepaws
were quantified as horizontal and vertical activity, respectively.
Rearing with the forepaws pressed against the walls was not
considered.
Spontaneous alternation was observed in a Y-maze (Duarte
et al., 2012a), with each arm of 30 cm long, 5 cm wide, and
25 cm height, converging to an equal angle. Mice were placed
at the bottom of one arm in the Y-maze and were allowed
to explore freely all three arms for a single 8-min session in
the dark. The recorded spontaneous alternation behavior was
used to access hippocampal-dependent spatial memory. If the
mouse remembers the arm it has just explored, it will then
enter the other arm of the maze instead. Complete spontaneous
alternation was defined as successive entries into the three arms
and expressed as fraction of the possible alternations in the
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respective test. In additionally to the open field test, the number of
entries in the arms of the maze also allowed to access locomotor
activity.
Magnetic Resonance Spectroscopy
(MRS)
All experiments were carried out in a 14.1 T magnet with
a horizontal bore of 26 cm (Magnex Scientific, Abingdon,
United Kingdom), equipped with a 12-cm internal diameter
gradient coil insert (400mT/m, 200µs), and interfaced to a
DirectDrive console (Agilent Technologies, Palo Alto, CA,
United States). Radio frequency transmission and reception
were achieved with a home-built quadrature surface coil
composed of two geometrically decoupled single-turn
loops of 12 mm inner diameter resonating at 600 MHz.
Spontaneously breathing mice were anesthetized with 1–1.5%
isoflurane (Animalcare Ltd., York, United Kingdom) in a
1:1 O2:air mixture, and fixed in a home-built mouse holder
with a bite bar and two ear inserts. Body temperature was
maintained at 37◦C by warm water circulation. Respiration
and temperature were continuously monitored using a MR-
compatible system (Small Animal Instruments, Inc., Stony
Brook, NY, United States). Volumes of interest (VOI) were
placed in the dorsal hippocampus (1.2 mm× 2.0 mm× 2.1 mm),
cortex (0.8 mm × 4.0 mm × 1.6 mm) or hypothalamus
(1.8 mm × 2.7 mm × 1.8 mm) according to anatomical
landmarks in T2-weighted fast-spin-echo images. Field
homogeneity in the VOI was achieved with FAST(EST)MAP
(Gruetter and Tkác, 2000). Spectra were acquired using SPECIAL
with echo time of 2.8 ms and repetition time of 4 s (Mlynárik
et al., 2006). We accumulated 210, 320, and 400 scans for the
cortex, hippocampus, and hypothalamus, respectively. The order
of scanning the regions was random.
The concentrations of brain metabolites were determined
with LCModel (Stephen Provencher Inc., Oakville, ON, Canada),
including a Mac spectrum in the database and using the
unsuppressed water signal measured from the same VOI as
internal reference (Gapp et al., 2017). The following metabolites
were included in the analysis: alanine, ascorbate, aspartate,
creatine, γ-aminobutyrate (GABA), glutamine, glutamate,
glutathione, glycine, glycerophosphorylcholine, glucose, lactate,
myo-inositol, N-acetylaspartate, N-acetylaspartylglutamate
(NAAG), phosphorylethanolamine, phosphorylcholine,
phosphocreatine, scyllo-inositol, taurine. The Cramér-Rao
lower bound (CRLB) was provided by LCModel as a measure
of the reliability of the quantification for each metabolite.
In most measured spectra, scyllo-inositol was below the
detection limit, and was excluded from subsequent data
analyses. Alanine in the hypothalamus was also below the
detection limit. Remaining metabolites had CRLB below 30%.
Given the substantial overlap between phosphorylcholine
and glycerophosphorylcholine signals, total choline levels are
reported.
Three mice (one on 45% fat diet, two on 60% fat diet)
were excluded from the study because of abnormally high
glutamine concentration in all brain regions investigated, which
suggests the occurrence of congenital portosystemic shunting
(Cudalbu et al., 2013).
Glucose Tolerance Test
After a 6-h fast starting at 07:00, a blood sample was collected to
determine glucose and insulin levels. Then mice were given an
oral load of glucose (1.5 g/kg), and blood glucose was measured
after 15, 30, 60, 90, and 120 min from the tail tip with the Breeze
glucometer (Bayer, Zürich, Switzerland).
Tissue Collection
Mice were briefly anesthetized with isoflurane (2% in air).
Glycemia under isoflurane anesthesia was measured using the
Ascensia Contour glucometer (Bayer). A blood sample was
collected from the descending aorta, and then mice were
decapitated. The brain was rapidly removed, and brain regions
were dissected in ice-cold phosphate-buffered saline (PBS; in
mmol/L: 137 NaCl, 2.7 KCl, 1.5 KH2PO4, 8.1 Na2HPO4, pH 7.4).
Brain and plasma samples were stored at −80◦C until further
processing.
Western Blot
Tissue samples were homogenized with a needle sonicator in
lysis buffer [in mmol/L: 150 NaCl, 1 ethylenediaminetetraacetic
acid (EDTA), 50 tris(hydroxymethyl)aminomethane (Tris)-HCl,
1% (v/v) Triton X-100, 0.5% (w/v) sodium deoxycholate,
0.5% (w/v) sodium dodecylsulfate (SDS), pH 8.0] containing
protease inhibitors (Roche, Switzerland). The homogenate
was then maintained in constant agitation for 2 h at 4◦C.
After centrifugation at 3,000 × g for 10 min at 4◦C
to remove major debris, the supernatant was saved. Total
protein content was determined with the bicinchoninic acid
assay (kit from Pierce, Thermo Fisher Scientific, Göteborg,
Sweden).
Samples were then diluted in NuPAGE-LDS sample buffer
[in mmol/L: 141 Tris-base, 106 Tris-HCl, 50 dithiothreitol, 0.51
EDTA, 0.22 Coomassie Brilliant Blue G-250, 0.175 phenol red; 2%
(w/v) lithium dodecylsulfate, 10% glycerol, pH 8.5] and heated
for 2 min at 95◦C, 2–20 µg of protein were loaded in precast
NuPAGE Novex 4–12% polyacrylamide gradient gels (Invitrogen,
Thermo Fisher Scientific), along with molecular weight standards
(Precision Plus Protein standards from Bio-Rad, Sundbyberg,
Sweden), and electrophoresis was carried out at 125 V in a
3-(N-morpholino)propanesulfonic acid (MOPS) running buffer
(in mmol/L: 50 MOPS, 50 Tris Base, 1 EDTA, 0.1% SDS, pH 7.7).
Proteins were transferred onto 0.45 µm polyvinylidene
difluoride membranes (GE Life Sciences, Sweden) in a buffer
composed of 192 mmol/L glycine, 25 mmol/L Tris and 20%
(v/v) methanol (pH 9.2). The membranes were subsequently
blocked for 90 min in 5% (w/v) low-fat milk (VWR,
Stockholm, Sweden) solution prepared in Tris-buffered saline
(TBS) (in mmol/L: 20 Tris, 137 NaCl, pH 7.46) with
0.1% (v/v) tween-20 (TBS-T), and were then incubated
with primary antibodies (Table 1) over night at 4◦C. After
three 15-min washes in TBS-T containing 1% (w/v) milk,
membranes were incubated with the respective secondary
antibodies conjugated with horseradish peroxidase (Table 1)
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TABLE 1 | Antibodies employed in the present study.
Antigen Host Dilution Supplier Molecular
weight (kDa)∗
Primary antibodies:
Gephyrin R 1:500 Abcam (#ab181382) 90–95
GFAP R 1:2,000 Abcam (#ab68428) 49–51
Iba-1 G 1:500 Sigma-Aldrich (#SAB2500041) 15–20
PSD-95 R 1:2,000 Abcam (#ab76115) 90–95
SNAP-25 R 1:5,000 Abcam (#ab109105) 25–26
Synaptophysin R 1:10,000 Abcam (#ab32127) 34–36
Syntaxin-1 R 1:1,000 Sigma-Aldrich (#S1172) 34–39
Syntaxin-4 R 1:1,000 Abcam (#ab184545) 31–39
vGAT R 1:1,000 Abcam (#ab42939) 53–55
vGluT1 R 1:2,000 Abcam (#ab180188) 61–62
vGluT2 R 1:1,000 Abcam (#ab216463) 63–65
HRP-conjugated secondary antibodies:
Rabbit IgG D 1 : 10 000 Abcam (#ab6802)
Goat IgG D 1 : 10 000 GeneTex (#GTX232040-01)
HRP, horseradish peroxidase; D, donkey; G, goat; R, rabbit. ∗Molecular weight
range observed in the present study.
for 1 h at room temperature. After the second antibody,
the membranes were washed three more times in TBS-
T and developed in the ChemiDoc (Bio-Rad) using the
SuperSignal West Pico PLUS Chemiluminescent substrate
(Thermo Scientific).
Biochemical Analyses
Plasma corticosterone and leptin were assayed with ELISA kits
from Abcam (Cambridge, United Kingdom). Plasma insulin
concentration was determined using the mouse insulin ELISA kit
from Mercodia (Uppsala, Sweden).
Statistical Analysis
All results were analyzed using analysis of variance (ANOVA),
followed by independent comparisons with the Fisher’s least
significant difference (LSD) test. For the analyses of metabolite
concentrations, the three brain regions were analyzed together as
repeated measures, and post hoc analyses were only performed
in case of significant effects of fat or fat-region interaction at
P < 0.05. Results are presented as mean ± SEM unless otherwise
stated.
RESULTS
Chronic exposure to HFD resulted in development of obesity,
mild hyperglycemia, glucose intolerance, and hyperinsulinemia
(Figure 1). Weight gain was proportional to the dietary fat
content (F = 64.2, P < 0.001, Figure 1A). Fed glycemia
was modified by HFD (F = 9.1, P = 0.001, Figure 1B),
being significantly increased in 60%-fat fed mice compared to
controls (+56 ± 14%, P < 0.001) and to 45%-fat fed mice
(+45 ± 13%, P = 0.002). Mice under 10%- and 45%-fat diets
showed similar fed glycemia. After fasting for 6 h, mice showed
a glycemia that was proportional to the amount of fat in the
diet (F = 23.1; P < 0.001, Figure 1C), while insulinemia was
similarly increased in both HFD groups compared to controls
(F = 9.2, P < 0.001, Figure 1D). The diet also had an effect on
the fasting glycemia to plasma insulin ratio (F = 3.6, P = 0.041)
that is commonly taken as an indicator of insulin sensitivity. In
particular, compared to controls (10%-fat fed mice), the ratio
of glucose to insulin was reduced by 94 ± 42% (P = 0.034)
and 95 ± 42% (P = 0.033) in mice from the 45%-fat or 60%-
fat groups, respectively. An oral glucose tolerance test after
this fasting period revealed an impairment of blood glucose
clearance that was also proportional to the amount of fat
present in the diet (F = 14.6, P < 0.001, Figure 1E). This is
especially clear when looking at the glycemia at 2 h post the
glucose administration (F = 13.5, P < 0.001, Figure 1F), with
60%-fat fed mice displaying increased glycemia compared to
both 45%-fat fed mice (+32 ± 14%, P = 0.033) and controls
(+109 ± 21%, P < 0.001). HFD also affected the circulating
concentrations of corticosterone (F = 4.2, P = 0.025, Figure 1G)
and leptin (F = 19.0, P < 0.001, Figure 1H). In post hoc
tests, corticosterone was only significantly different between mice
under diets with 10% and 60% fat (+32 ± 11%, P = 0.007), while
leptin was similarly increased in both HFD groups compared to
controls.
Spatial Memory
Exposure to HFD resulted in impaired spatial memory
performance, measured as spontaneous alternation in the Y-maze
(F = 3.8, P = 0.030, Figure 2A). In particular, there was
a reduction of the Y-maze spontaneous alternation in mice
consuming both the 45%-fat diet (−11 ± 5%, P = 0.028) and
60%-fat diet (−10 ± 4%, P = 0.025), relative to controls. Diet
also had an effect on the number of entries in the maze arms
(F = 8.2, P = 0.001), but not resulting in major impairment
of exploratory behavior, which was also assessed in the open-
field test (Figure 2B). Nevertheless, mice exposed to both
45%-fat and 60%-fat diets showed a reduction in locomotor
activity, that is reduced number of crossing events between
quadrants of the arena (F = 5.5, P = 0.008), and reduced
vertical explorations of the arena’s space, that is rearing events
(F = 3.8, P = 0.030). Nevertheless, the observed reduction
activity did not impair the analysis of spontaneous alteration
behavior as it is normalized for the number of possible complete
alternations, and there were sufficient arm entries in the Y-maze
(Figure 2A).
Metabolic Profiles
Proton spectra were acquired with an average SNR of 18 ± 3
(standard deviation across all brain areas). Typical spectra are
shown in Figure 3. Linewidths at half-height were 11.2± 3.0 Hz,
16.2 ± 4.0 Hz and 13.6 ± 2.2 Hz (mean with standard deviation)
in the hippocampus, cortex and hypothalamus, respectively.
The amount of fat in the diet significantly impacted the levels
of creatine (F = 13.7, P < 0.001, Figure 4A), which also varied
across analyzed brain areas (region effect F = 55.1, P < 0.001;
interaction F = 0.9, P = 0.506). Although phosphocreatine levels
were not impacted by HFD exposure (Figure 4B), the content
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FIGURE 1 | HFD-induced changes on body weight (A), fed glycemia (B), glycemia (C), and plasma insulin (D) after a 6-h fasting, area under the curve (AUC) of an
oral glucose tolerance test (OGTT) with 1.5 g/kg of glucose (E) and glycemia measured 2 h after the glucose load (F), and plasma corticosterone (G) and leptin (H)
concentrations. Data are mean ± SEM. Symbols indicate significant differences in LSD tests after significant ANOVA, comparing HFD fed mice (45% fat or 60%-fat)
and controls (10%-fat; ∗P < 0.05, ∗∗P < 0.01; ∗∗∗P < 0.001), or the diets containing 45% and 60% fat (§ P < 0.05, §§ P < 0.01).
FIGURE 2 | Impact of HFD exposure on the performance in the Y-maze (A)
and the open-field arena (B). Data are mean ± SEM. Symbols indicate
significant differences in LSD tests after significant ANOVA, comparing HDF
fed mice (45% fat or 60%-fat) and controls (10%-fat; ∗P < 0.05, ∗∗P < 0.01;
∗∗∗P < 0.001), or the diets containing 45% and 60% fat (§ P < 0.05).
of fat was associated to reductions of the phosphocreatine-
to-creatine ratio (F = 13.1, P = 0.009, Figure 4C), which
suggests impaired energy metabolism. This effect was particularly
prominent in the cortex (−31%, P = 0.003) and hypothalamus
(−20%, P = 0.050), and not significant in the hippocampus
(−13%, P = 0.303) of the 60%-fat group compared to controls.
High-fat diet caused a general increase of glutamine levels
(F = 7.9, P = 0.050, Figure 4D), and there was also an effect of
brain region on glutamine levels (region F = 33.3, P < 0.0001;
interaction F = 0.9, P = 0.717), and post hoc analyses revealed
a significant increase the hippocampus of mice fed 60%-fat diet
relative to controls (+21 ± 10%, P = 0.036), as well as relative
to mice fed 45%-fat diet (+27 ± 10%, P = 0.011). Interestingly
glutamate levels were not significantly affected by the diet
(Figure 4E). Brain concentrations the neuro-transmitting amino
acids GABA (Figure 4F), glycine (Figure 4G), and aspartate
(Figure 4H) also remained unaltered by HFD exposure.
The levels of the neuronal marker N-acetylaspartate showed a
significant diet-region interaction (interaction F = 6.7, P = 0.006;
region F = 44.2, P < 0.001; fat F = 4.5, P = 0.066, Figure 4I).
Post hoc analyses identified an increase of N-acetylaspartate
concentration in the hippocampus of mice exposed to 60%-fat
diet compared to controls (+11± 4%, P = 0.007), and compared
to 45%-fat fed mice (+18± 4%, P < 0.001).
N-Acetylaspartylglutamate levels were modified by fat content
in the diet (F = 12.8, P = 0.015, Figure 4J) and varied
across brain areas (F = 20.4, P < 0.001), without interaction
(F = 0.5, P = 0.918). However, no significant changes were
detected in post hoc analyses between controls and mice
in either HFD group. However, significant differences were
observed between 45%-fat and 60%-fat groups in the cortex
(+36 ± 22%, P = 0.005) and hippocampus (+46 ± 20%,
P = 0.046).
We found a diet-region interaction effect on the concentration
of glutathione (interaction F = 9.8, P = 0.047; region F = 10.9,
P = 0.006; diet F = 2.7, P = 0.247, Figure 4K). Post hoc analyses
showed a significant increase of hippocampal glutathione levels
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FIGURE 3 | Typical spectra recorded from the mouse hippocampus, cortex and hypothalamus. Spectra were acquired with SPECIAL at 14.1 T. For signal
enhancement of the displayed spectra, a Gaussian apodization (gf = 0.08, gfs = 0.02) was applied prior Fourier transformation. Lac, lactate; Ala, alanine; GABA,
γ-aminobutyrate; NAA, N-acetylaspartate; NAAG, N-acetylaspartylglutamate; Glu, glutamate; Gln, glutamine; Asp, aspartate, Cr, creatine; PCr, phosphocreatine;
tCho, total choline-containing compounds; Tau, taurine; Ins, myo-inositol.
in the 60%-fat group compared to controls (+35 ± 13%,
P = 0.011). The concentrations of the antioxidant Asc were not
significantly modified by HFD exposure (Figure 4L).
There was a significant diet-region interaction effect on the
concentration of myo-inositol (interaction F = 4.9, P = 0.029;
region F = 45.4, P < 0.001; diet F = 5.2, P = 0.071, Figure 4M).
Post hoc analyses indicated that the increase of myo-inositol was
exclusive to the hypothalamus (+18 ± 5%, P < 0.001 for mice
exposed to 60%-fat diet vs. controls; and+18± 5%, P< 0.001 vs.
45%-fat).
High-fat diet caused an increase of taurine levels (F = 1.3,
P = 0.047, Figure 4N), which also varied across the three
brain regions (F = 85.9, P < 0.001) without diet-region
interaction (F = 0.2, P = 0.788). Post hoc analyses showed a
significant difference of hippocampal taurine content between
the mice exposed 60%-fat diet and controls (+12 ± 0.5%,
P = 0.022).
The concentration of total choline-containing compounds was
affected by HFD exposure (F = 6.8, P = 0.001, Figure 4O)
and varied across brain regions (F = 68.1, P < 0.001) without
interaction between the two factors (F = 1.8, P = 0.149). The
content of total choline was significantly higher in mice exposed
to 60%-fat diet in the hippocampus (+17 ± 6%, P = 0.007 vs.
controls; +14 ± 6%, P = 0.018 vs. 45%-fat) and hypothalamus
(+16 ± 4%, P < 0.001 vs. controls; +15 ± 4%, P < 0.001 vs.
45%-fat), but not in the cortex.
A significant diet-region interaction effect was observed on
phosphorylethanolamine levels (interaction F = 8.7, P = 0.022;
region F = 19.8, P < 0.0001; fat F = 3.2, P = 0.252,
Figure 4P). Post hoc analyses identified a 40 ± 16% reduction
of phosphorylethanolamine concentration in the cortex of mice
exposed to 45%-fat diet compared to controls (P = 0.017). Such
reduction in mice exposed to the 60%-fat diet did not reach
statistical significance (−24± 17%, P = 0.148). The concentration
of phosphorylethanolamine in the hypothalamus was different
between the two HFD groups (P = 0.009).
Brain glucose levels were increased with the amount of fat in
the diet (F = 12.6, P = 0.037, Figure 4Q) with no region (F = 0.8,
P = 0.513) or interaction (F = 4.4, P = 0.146) effects. Compared
to control mice, mice exposed to 60%-fat diet displayed a
glucose concentration increase of 84 ± 25% in the hippocampus
(P < 0.001) and of 41 ± 20% in the cortex (P = 0.049), but
negligible in the hypothalamus (+16± 21%, P = 0.442).
We observed a significant diet-region interaction effect
on the levels of lactate (interaction F = 11.9, P = 0.005,
region F = 10.1, P = 0.002, fat F = 6.9, P = 0.080,
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FIGURE 4 | Concentrations of metabolites in the hippocampus (hippoc.), cortex and hypothalamus (hypothal.) of mice fed diets containing 10%, 45%, and 60% fat.
Panels (A–S) show alterations of each metabolite as presented in the text. Data are mean ± SEM (µmol/g). Symbols indicate significant differences in LSD tests after
significant ANOVA, comparing HFD fed mice (45% fat or 60%-fat) and controls (10%-fat; ∗P < 0.05, ∗∗P < 0.01; ∗∗∗P < 0.001), or the diets containing 45% and
60% fat (§ P < 0.05, §§ P < 0.01, §§§ P < 0.001).
Figure 4R). Post hoc analyses identified an increase of lactate
concentration in the hypothalamus of mice exposed to 60%-
fat diet compared to controls (+36 ± 16%, P = 0.025), and
compared to 45%-fat fed mice (+84 ± 21%, P < 0.001). Levels
of alanine were not significantly modified by HFD exposure
(Figure 4S).
Synaptic Degeneration
In order to infer on synaptic degeneration, we measured the
density of proteins located in synapses (Figure 5). Levels of
synaptophysin were not significantly impacted by HFD exposure
in any of the brain regions investigated (hippocampus F = 2.4,
P = 0.112; cortex F = 1.5, P = 0.250; hypothalamus F = 0.4,
P = 0.661), although one may notice a tendency for reduced
synaptophysin content in the hippocampus of HFD mice relative
to controls (P = 0.054 and P = 0.090 for 45% and 60%-fat
versus controls, respectively). Also levels of syntaxin-1 were
similar across experimental groups in the hippocampus (F = 0.9,
P = 0.414), cortex (F = 1.8, P = 0.240) and hypothalamus
(F = 0.3, P = 0.764). The synaptosomal-associated protein
SNAP-25 was modified in the hippocampus of HFD-exposed
mice (F = 6.8, P = 0.029), but not in the cortex or hypothalamus.
In particular, SNAP-25 in the hippocampus on mice the fed 60%-
fat diet was reduced by 25 ± 8% (P = 0.021) when compared
to controls and by 26 ± 8% (P = 0.017) when compared to
45%-fat fed mice. Levels of syntaxin-4, which is another protein
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FIGURE 5 | HFD-induced changes on levels of synaptic proteins. (A) Shows typical Western blot of synaptophysin (B), syntaxin-1 (C), SNAP-25 (D), syntaxin-4 (E),
PSD-95 (F), and gephyrin (G). Samples from three mice of each group were loaded in SDS-PAGE gels (2 µg of protein of syntaxin-1 and synaptophysin, 5 µg of
protein for the remaining proteins). Measured immunoreactivity was normalized to the average of the three controls (10%-fat group, white bar) to allow pooling data
from different gels. Data are mean ± SEM of n = 6. Symbols indicate significant differences in LSD tests after significant ANOVA, comparing HFD fed mice (45% fat
or 60%-fat) and controls (10%-fat; ∗P < 0.05, ∗∗P < 0.01; ∗∗∗P < 0.001), or the diets containing 45% and 60% fat (§ P < 0.05, §§ P < 0.01).
of the exocytosis machinery of nerve terminals but mainly
occurring in processes of astrocytes (Tao-Cheng et al., 2015),
were reduced in the hippocampus (F = 9.2, P = 0.002) but
not cortex (F = 0.1, P = 0.932) or hypothalamus (F = 0.1,
P = 0.887). In particular, when compared to controls, syntaxin-
4 in the hippocampus was reduced by 19 ± 5% (P = 0.011) and
27 ± 7% (P < 0.001) in mice fed 45%-fat and 60%-fat diets,
respectively.
Proteins from the post-synaptic region of synapses were also
modified by HFD feeding. Diet impacted the postsynaptic density
protein PSD-95 levels in the hippocampus (F = 8.1, P = 0.002)
but not cortex (F = 2.9, P = 0.076) or hypothalamus (F = 3.3,
P = 0.067). PSD-95 levels were reduced in the hippocampus
of mice fed the 60%-fat diet by 30 ± 7% (P = 0.012) when
compared to controls, and by 38 ± 13% (P < 0.001) when
compared to mice fed the 45%-fat diet. Levels of gephyrin,
another protein from the post-synaptic zone, varied with the
amount of fat in the diet in the hippocampus (F = 3.8, P = 0.044),
cortex (F = 8.8, P = 0.003) and hypothalamus (F = 3.9,
F = 0.035). Compared to controls, the 45%-fat diet caused a
significant reduction of gephyrin levels in the hippocampus
(−16 ± 5%, P = 0.014). In the cortex, 60%-fat diet mice showed
reduced gephyrin relative to the other groups (−13 ± 3%,
P = 0.002 vs. controls; −12 ± 4%, P = 0.004 vs. 45%-fat diet).
In the hypothalamus there was a reduction of −18 ± 8% in
gephyrin levels in mice fed 45%-fat diet versus 60%-fat diet
(P = 0.011).
We further measured the relative levels of vesicular glutamate
and GABA transporters (vGluT1/2 and vGAT; Figure 6). The
amount of fat in the diet was associated with a reduction of
vGluT1 levels in the mouse hippocampus (F = 7.9, P = 0.005)
and hypothalamus (F = 4.3, P = 0.033) but not in the cortex
(F = 1.5, P = 0.297). In the hippocampus, both 45%-fat and
60%-fat fed mice showed significantly reduced vGluT1 levels
when compared to controls (−38 ± 9%, P = 0.001 for 45%-
fat diet; −22 ± 7%, P = 0.032 for 60%-fat diet). The same
was observed in the hypothalamus (−39 ± 14%, P = 0.015
for 45%-fat diet; −32 ± 16%, P = 0.039 for 60%-fat diet).
HFD exposure impacted levels of vGluT2 in the mouse cortex
(F = 10.3, P = 0.001) and hypothalamus (F = 3.9, P = 0.043)
but not in the hippocampus (F = 0.3, P = 0.748). In the
cortex, mice fed 60%-fat diet showed increased cortical vGluT2
relative to the other groups (+25 ± 6%, P < 0.001 vs. controls;
+24 ± 7%, P = 0.001 vs. 45%-fat diet). In the hypothalamus,
we observed a significant reduction of vGluT2 levels in mice
fed 45%-fat diet (−28 ± 8%, P = 0.014 vs. controls). Levels
of vGAT were affected by HFD exposure in the hippocampus
(F = 3.6, P = 0.044) and hypothalamus (F = 3.6, P = 0.049). The
hippocampus of mice exposed to both 45%-fat and 60%-fat diet
showed less vGAT levels than controls (−25 ± 9%, P = 0.024
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FIGURE 6 | HFD-induced changes on levels of vesicular glutamate and GABA
transporters. (A) Shows representative Western blots of vGluT1 (B), vGluT2
(C), and vGAT (D). Samples from three mice of each group were loaded in
SDS-PAGE gels (20 µg of protein). Measured immunoreactivity was
normalized to the average of the three controls (10%-fat group, white bar) to
allow pooling data from different gels. Data are mean ± SEM of n = 6.
Symbols indicate significant differences in LSD tests after significant ANOVA,
comparing HFD fed mice (45% fat or 60%-fat) and controls (10%-fat;
∗P < 0.05, ∗∗P < 0.01), or the diets containing 45% and 60% fat (§§
P < 0.01).
for 45%-fat diet; −22 ± 10%, P = 0.042 for 60%-fat diet). In
the hypothalamus, the reduction of vGAT was significant only
in mice exposed to 45%-fat diet (−25 ± 10%, P = 0.018 vs.
controls).
Gliosis Markers
To infer on the modification of glial compartments, we measured
the levels of glia-specific proteins (Figure 7). The glial fibrillary
acidic protein (GFAP) that is specific to astrocytes was modified
by fat levels in the diet in the hypothalamus (F = 7.8, P = 0.005),
but not in the hippocampus (F = 1.6, P = 0.235) and cortex
(F = 2.6, P = 0.155). Relative to controls, the hypothalamus of
mice exposed to 45%-fat diet displayed a 38 ± 7% increase of
GFAP immunoreactivity (P = 0.003), and a similar increase was
observed for mice on the 60%-fat diet (+35 ± 12%, P = 0.005).
Also the ionized calcium-binding adapter molecule 1 (iba-1), a
protein present in microglial cells, showed increased levels in the
hypothalamus (F = 3.5, P = 0.045), but not in the hippocampus
(F = 1.1, P = 0.352) and cortex (F = 1.1, P = 0.360). In particular,
there was a 31 ± 10% increase of iba-1 immunoreactivity in
FIGURE 7 | HFD-induced changes on levels of glia-specific proteins.
(A) Shows typical Western blot of GFAP (B) and Iba-1 (C). Samples from
three mice of each group were loaded in SDS-PAGE gels (20 µg of protein).
Measured immunoreactivity was normalized to the average of the three
controls (10%-fat group, white bar) to allow pooling data from different gels.
Data are mean ± SEM of n = 6. Symbols indicate significant differences in
LSD tests after significant ANOVA, comparing HFD fed mice (45% fat or
60%-fat) and controls (10%-fat; ∗P < 0.05, ∗∗P < 0.01). No significant
differences were observed between the two HFD groups.
the hypothalamus of mice exposed to 60%-fat diet compared to
controls (P = 0.014).
DISCUSSION
The present results show that mice chronically exposed to a lard-
based HFD develop glucose intolerance associated to reduced
insulin sensitivity, impaired hippocampal-dependent spatial
memory, and neurochemical alterations in the hippocampus,
cortex and hypothalamus. While metabolic profiles of the
hippocampus, cortex and hypothalamus were modified in
mice fed 60%-fat but not 45%-fat diet, when compared to
controls, memory dysfunction was observed in both HFD
groups. Accordingly, levels of proteins required for adequate
synaptic function were found modified in mice fed diets
containing fat at either 45% or 60%, relative to controls. This
indicates that synaptic dysfunction may occur in the brain
upon diet-induced obesity in the absence of major changes of
metabolite concentrations. Nevertheless, this does not exclude
the presence of alterations in the rate of certain metabolic
pathways.
Modifications of Energy Metabolism
A general reduction of the phosphocreatine-to-creatine ratio
was prominent in 60%-fat fed mice, when compared to the
other groups, which suggests a disruption of mechanisms
regulating metabolism and maintaining the cellular energy
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status in the brain. HFD exposure resulted in changes of
glucose concentration in the hippocampus and cortex that
were parallel to the changes in fed glycemia. However, this
was not observed in the hypothalamus, where glucose levels
were similar in all diets tested. This suggests that glucose
transport and metabolism is differently adapted to the mild
hyperglycemia state of 60%-fat fed mice, likely related to the
glucose-sensing ability of the hypothalamus. In line with this,
the hypothalamus of mice exposed to 60%-fat, but not the
hippocampus and cortex, displayed higher levels of lactate
than the other experimental groups. The measurement of basal
metabolite concentrations, however, does not provide insight
into metabolic pathways, namely glycolysis and tricarboxylic
acid cycle. By employing 13C MRS with 13C-labeled glucose
we have previously demonstrated that energy metabolism is
altered in the hypothalamus upon high-fat feeding (Lizarbe
et al., 2018). Modifications of brain energy metabolism were
reported in rats fed a fat-rich diet for 3 weeks, namely reduced
glucose utilization and increased astrocytic metabolism (Melø
et al., 2006). Recently, we also reported that a rat model of
lean T2D, the Goto-Kakizaki rat, displays impaired neuronal
oxidative metabolism and reduced glutamate-glutamine cycle
rate, as well as exacerbated oxidative metabolism in astrocytes
(Girault et al., 2018). The relative contributions of fatty
acids and glucose as available brain energy substrates, and of
neurodegeneration-associated metabolic changes to brain energy
dysfunction deserve further investigation. Previous experiments
suggest that HFD exposure increases the utilization of fat in
detriment of glucose oxidation, at least in the hypothalamus
(Lizarbe et al., 2018). This observation, together with the present
findings of higher lactate and lower glucose concentrations,
leads us to speculate that long-term HFD exposure results in
increased glycolysis in for lactate production while other available
substrates, such as fats, are metabolized in the tricarboxylic acid
cycle.
Osmolarity Regulation
Changes of the phosphocreatine-to-creatine ratio were due to
increases in the creatine concentration rather than decreases
of phosphocreatine (see Figures 4A–C), which is in line
with the relevance of creatine levels for osmolarity regulation.
Osmolarity control in the brain is considered to occur via
the concentrations of not only creatine but also taurine and
myo-inositol, since hyper-osmolarity causes their accumulation
(Gullans and Verbalis, 1993). Also N-acetylaspartate, which is
present in large concentrations in neurons, has been proposed to
act as a brain osmolyte (Taylor et al., 1994; Gotoh et al., 1997),
and is effectively released to the interstitial space upon osmotic
challenges (Sager et al., 1997; Bothwell et al., 2001). Accordingly,
taurine and N-acetylaspartate in the hippocampus, and myo-
inositol in the hypothalamus were also increased upon exposure
to 60% but not 45% fat in the diet. It should be noted that
these modifications in brain osmolytes follow the plasma glucose
concentration in the fed state, as well as corticosterone levels,
which were significantly higher in 60%-fat fed mice than the other
groups. Indeed, in addition to chronic hyperglycemia, it cannot
be excluded that glucocorticoid-mediated signaling plays a role
in diabetes-induced impaired brain metabolism and function
(discussed in Girault et al., 2018).
Metabolic Indications of
Neurodegeneration
N-Acetylaspartate reductions are often associated to impaired
mitochondrial integrity in neurons, as well as lipid and
myelin biosynthesis (Duarte et al., 2012b). Metabolism of
N-acetylaspartate is compartmentalized between neurons and
oligodendrocytes and serves for myelination. N-acetylaspartate
is mainly stored in neurons, being synthesized from
mitochondrial acetyl-CoA and Asp (Baslow, 2003), and
its de-acetylation occurs in oligodendrocytes (Kirmani
et al., 2002), where it can replenish both acetyl-CoA and
oxaloacetate (through aspartate) pools providing carbon
skeletons for both energy production and local lipid synthesis,
required in the myelination process. In line with this role
of N-acetylaspartate, Canavan disease is characterized by
accumulation of N-acetylaspartate due to impaired de-
acetylation in oligodendrocytes, which is associated to defects
in myelin synthesis and deposition (Chakraborty et al., 2001).
Indeed, it was recently suggested that high-fat feeding has
an impact on myelination, namely by promoting the loss of
oligodendrocyte progenitor cells and mature oligodendrocytes
(Yoon et al., 2016).
A significant increase of hippocampal glutathione levels was
observed in the 60%-fat group relative to controls, while there
was a tendency for reduced glutathione levels in the cortex.
It should be noted that the levels of glutathione measured by
MRS include both reduced and oxidized forms, which are not
distinguishable. Although lower ratio of reduced-to-oxidized
glutathione has been reported in short-term HFD feeding (e.g.,
Alzoubi et al., 2018), no change of brain levels of oxidized
and reduced glutathione, or their ratio upon long-term HFD
exposure (Li et al., 2013). It should be noted however that
Li et al. (2013) reported a non-significant increase of 15–20%
of hippocampal reduced glutathione in high- versus low-fat-
fed mice, in line with the present observation. It is likely
that a total glutathione increase in the hippocampus might
reflect a compensatory mechanism to oxidative stress upon
chronic HFD exposure. In fact, the brain of HFD-fed mice
displays impaired redox homeostasis, including: (1) enhanced
activity of enzymes that generate free radicals, such as xanthine
oxidase or NADPH oxidase; (2) reduced activity of enzymes
with antioxidant action, namely glutathione peroxidase and
catalase; (3) increased concentration of free radicals; (4) and
oxidative damage to lipids and proteins (e.g., Morrison et al.,
2010; Li et al., 2013; Charradi et al., 2017; Liu et al., 2017;
Alzoubi et al., 2018; Maciejczyk et al., 2018). Accordingly, the
hippocampus of mice fed a 60%-fat diet for 4 months also
shows impaired signaling mediated by the transcription factor
NRF2 which protects against brain oxidative damage (Morrison
et al., 2010). Namely, Morrison et al. (2010) reported HFD-
induced reductions of NRF2 protein levels, NRF2-DNA binding
activity, and levels of the NRF2 responsive proteins in the
hippocampus.
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Interestingly, impaired cellular redox regulation in the brain
has been proposed to impact oligodendrocyte proliferation
(consistent with increased levels of N-acetylaspartate, discussed
above), which has implications on the maintenance of myelin
sheets around axons, and thus brain connectivity (see Corcoba
et al., 2016 and references there in).
The content of total choline was significantly higher
in hippocampus and hypothalamus, but not cortex. The
main contributors to the choline peaks in MRS are the
water-soluble glycerophosphorylcholine and phosphorylcholine,
which are involved in membrane lipid metabolism (Duarte
et al., 2012b). Namely, it is precursor of phosphatidylcholine
and, in turn, of sphingomyelin, which is necessary for
adequate myelination of axons (Oshida et al., 2003), and
is implicated in immune responses (Li et al., 2015). In
contrast to phosphorylcholine, a HDF-induced reduction of
phosphorylethanolamine concentration was observed in the
cortex. It is interesting to note that besides these changes in
the concentration of phosphorylethanolamine in the cortex, no
other significant metabolic alterations were observed between
mice fed the diet containing 45% of fat and those in the
control group. Altogether, these results point to alterations on
phospholipid metabolism with possible implications on plasma
membrane permeability, maintenance of action potentials and
conduction of electric impulses, and on events that involve
membrane deformation, fusion and fission, such as transcellular
signaling, vesicular release of neurotransmitters, gliotransmitters
or neuromodulators, mitochondrial dynamics, and autophagy
(Aureli et al., 2015; Krols et al., 2016; Lauwers et al., 2016; van
Echten-Deckert and Alam, 2018). In addition, lipid metabolism
is important for membrane reorganization of astrocytes and
microglia in neuroinflammation, which have been proposed to
be reflected on MRS-detected changes of choline-containing
compounds (discussed in Duarte et al., 2012b). In our study,
total choline increased with HFD in the hippocampus and
hypothalamus, while increased levels of GFAP and Iba-1,
which are signs of inflammation, were exclusively observed
in the hypothalamus. These results support the notion that
MRS markers do not distinguish neuroinflammation from
neurodegeneration and other processes (Zahr et al., 2014;
Pardon et al., 2016).
Taurine is an amino acid that, although it is present at
1 µmol/g in the human brain, it reaches relatively large
concentrations in the rodent brain (above 5 µmol/g in rats and
above 8 µmol/g in mice; Duarte, 2016), thus playing a major role
as osmolyte (Duarte et al., 2009 and references therein). Taurine is
released from both neurons and glial cells (Hada et al., 1998), and
acts as an agonist at receptors of the GABAergic and glycinergic
neurotransmission systems (Albrecht and Schousboe, 2005). In
the present study, HFD exposure caused a reduction of proteins
associated to inhibitory neurotransmission (gephyrin and vGAT),
suggesting that increased taurine might be a compensatory
mechanism for the loss of inhibitory tone. Moreover, taurine is
transported into the mitochondrial matrix where it buffers pH
to the optimal value for isocitrate dehydrogenase, which is one
of the key enzymes of the tricarboxylic acid cycle regulating
energy metabolism and oxidative phosphorylation, contributes
to stabilize the pH gradient across the inner-membrane, and
thus helps preserving mitochondrial function and preventing
oxidative damage (Hansen et al., 2010). Therefore, this HFD-
induced increase of taurine levels in the is likely a beneficial
adaptation of the brain.
Microgliosis and Astrogliosis
Increased levels of myo-inositol have been suggested to represent
astrogliosis in the neurodegeneration-associated inflammatory
process (discussed in Duarte et al., 2012b). The HFD-associated
increased myo-inositol of the present study was exclusive to
the hypothalamus. Interestingly, the hypothalamus was also
the sole brain region to show significantly HFD-associated
increased levels of glial specific proteins, namely GFAP and
Iba-1 that are present in astrocytes and microglia, respectively.
This overexpression of GFAP and Iba-1 is thus indicative of
HFD-associated hyper-reactivity of astrocytes (astrogliosis) and
microglia (microgliosis), as we reported recently (Lizarbe et al.,
2018). Brain disorders are accompanied by neuroinflammation
with astrogliosis and microgliosis generally in response to
damage of nearby neuronal processes, but gliosis might become
deleterious for the neurons upon chronicity (López-Valdés and
Martínez-Coria, 2016). A transient increase in levels of pro-
inflammatory cytokines was observed in the hypothalamus
within 1–3 days of HFD exposure (e.g., Thaler et al., 2012; Waise
et al., 2015), which might constitute a protective or reparative
inflammatory process. In contrast, the hypothalamic gliosis in
chronic HFD exposure (present study) is likely neurotoxic and
has been suggested to participate in the genesis of obesity-
associated diabetes since it may cause alterations of food intake,
energy expenditure, insulin secretion, hepatic glucose production
and metabolism of glucose and fats (Rahman et al., 2018).
The hippocampus and cortex of HFD-exposed mice did
not show signs of gliosis, when compared to controls (no
significant increase in levels of myo-inositol, GFAP or Iba-1).
Despite the general consensus that neuroinflammation and
astrogliosis occur in insulin resistance and T2D (Saravia et al.,
2002; Baydas et al., 2003; Duarte et al., 2009, 2012a; Calvo-
Ochoa et al., 2014), conflicting results have been reported
regarding astrogliosis in memory-related brain areas upon HFD
exposure. This is likely due to the distinct study designs, diet
compositions, fat origin, age and/or species. Recent studies
do not find HFD-induced increased levels of GFAP in the
rat hippocampus (Raider et al., 2016; Ribeiro et al., 2018). In
contrast, Tarantini et al. found that mice exposed to a 60%-
fat diet from 3 to 8 months of age show mild behavior deficits
and neuroinflammation, which are exacerbated by exposure
to a cellular stress induced by deletion of the transcription
factor nrf2 that regulates the expression of antioxidant proteins,
thus protecting against oxidative damage (Tarantini et al.,
2018). A particularly interesting study by Tsai et al. (2018)
found that GFAP levels increase in the hippocampus of mice
exposed to 60%-fat diet for 3 months, relative to controls,
and that HFD consumption leads to a reduction of the length
and ramification of astrocytic processes in the CA1 and CA3
regions but not the dentate gyrus of the hippocampus. This
retraction of astrocytic processes is of importance for the
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metabolic support that astrocytes should provide to neurons
and their synapses (Sonnay et al., 2017), and in fact Tsai et al.
(2018) also reported that HFD reduced levels of the astrocytic
glutamate carriers GLT-1 and GLAST in the hippocampus,
without changes of glutamine synthase levels. Soontornniyomkij
et al. (2016) also found that 5 months of HFD exposure does
not change levels of glutamine synthetase in the hippocampus
of 5-month-old mice, although HFD increases the density of
this protein in aged mice. Altogether, these observations suggest
impaired glutamate-glutamine cycle rate that, in turn, may result
in glutamatergic dysfunction and consequent accumulation of
glutamine in astrocytes. Consistent with impaired glutamate
release, we observed reduced levels of vesicular glutamate
transporters, mainly vGluT1. However, care should be taken
when interpreting changes on levels of carriers and enzymes
because they may not reflect changes of their activity in the brain
in vivo.
Moreover, as mentioned above, observations from different
diet-induced obesity studies should be compared with caution.
For example, in contrast to the reduced levels of glutamate
carriers caused by a 60% HFD (Tsai et al., 2018), hippocampal
slices prepared from mice fed a 45%-fat diet for only
2 months displayed enhanced glutamate uptake, increased
density of glutamate carriers and reduced levels of the
glutamate degrading enzymes glutamine synthetase and GABA-
decarboxylase, compared to slices from controls (Valladolid-
Acebes et al., 2012). Based on our results, we believe that the
exposure to diets containing fat at 45% or 60% elicits different
degenerative processes rather than resulting from a simple dose-
response phenotype.
Glutamine synthesis takes place in astrocytes (Sonnay et al.,
2017). In our study, HFD caused indeed an increase of glutamine
levels in the 60%-fat group (but not the 45%-fat) relative to
controls, which was particularly significant in the hippocampus.
In line with our observations, increased hippocampal glutamine-
to-creatine ratio was recently reported in Wistar rats exposed
to a 60%-diet from 8 to 12 months of age (Ribeiro et al.,
2018). In young adult Fisher 344 rats under a 60%-fat diet for
5 months, Raider et al. (2016) also observed a tendency for
higher hippocampal glutamine concentration, and a significantly
increased glutamine-to-glutamate ratio, relative to controls.
This study, however, reported lower levels of myo-inositol and
creatine in high versus low fat-fed rats (Raider et al., 2016),
contrasting to the findings of the present study (discussed
above).
Dysfunction in Excitatory and Inhibitory
Synapses
N-Acetylaspartylglutamate (NAAG) levels increased in the cortex
and hippocampus with HFD exposure. Similar NAAG changes
were observed in HFD-exposed rats (Raider et al., 2016).
NAAG is synthetized from ATP-dependent condensation of
N-acetylaspartate and glutamate in neurons, packed into synaptic
vesicles of presynaptic terminals, including those of pyramidal
neurons in the cortex and limbic system, is co-released with
glutamate, and acts as an antagonist of the glycine site of
the NMDA receptor (Duarte and Xin, 2018 and referenced
therein). Importantly, NAAG also acts on the metabotropic
type II glutamate receptor mGluR3 inhibiting the release of
neurotransmitters, such as glutamate, GABA and glycine (Neale,
2011). In HFD-exposed mice, increased NAAG levels would
thus reduce glutamatergic neurotransmission by both inhibiting
the activity of NMDA receptors and augmenting the negative
feedback of glutamate release through its agonist action on
presynaptic mGluR3 receptors. High NAAG concentration might
prevent glutamate excitotoxicity, which is important when
astrocytes have impaired glutamate clearance (see above), but on
the other hand sufficient glutamatergic activity is necessary for
proper function, including memory performance.
Consistent with reduced rate of the glutamate-glutamine
cycle and with synaptic dysfunction in general, we observed a
reduction in the levels of some pre- and post-synaptic proteins
and of vesicular glutamate and GABA transporters in mice
exposed to diets containing either 45% or 60%, relative to
controls. We measured the density of two presynaptic proteins
that are target SNARE (Soluble N-ethylmaleimide-sensitive
factor Attachment protein REceptor) proteins required for vesicle
fusion, namely syntaxin-1 and SNAP-25 (Söllner et al., 1993),
and the density of synaptophysin that is a major component of
presynaptic vesicles (Valtorta et al., 2004). SNAP-25 was reduced
in the hippocampus of mice fed 60%-fat diet, when compared
to controls, and there was also a tendency for hippocampal
synaptophysin levels to be reduced with increasing fat content
in the diet. Similar results were found for the density of vGluT1
and vGAT in the hippocampus, which suggest a reduction of
the number of excitatory and inhibitory synaptic vesicles that
are available for neurotransmission. Deficits in gliotransmission
cannot be excluded since vesicular transporters are present in
both neurons and astrocytes (see Schubert et al., 2011 and
references therein). Therefore, we further measured the levels
of syntaxin-4. While syntaxin-1 is mostly located in neurons,
namely in the plasma membrane of the presynaptic terminal,
syntaxin-4 is particularly concentrated in glial cells, namely in
peri-synaptic astrocytic processes (Schubert et al., 2011; Tao-
Cheng et al., 2015). In fact, the level of syntaxin-4 was also found
reduced in the hippocampus of mice from either HFD group,
confirming also a dysfunction at the level of gliotransmission.
We further measured the density of PSD-95 that is associated
to excitatory postsynaptic densities (Hunt et al., 1996), and
gephyrin that is present at the inhibitory postsynaptic density,
where it interacts with glycine and γ-aminobutyric acid type A
(GABAA) receptors (Maric et al., 2011). In the hippocampus,
HFD also led to a reduction of PSD-95 (60%-fat group only)
and of gephyrin (only significant for 45%-fat), compared to
controls. Reduced level PSD-95 in the hippocampus of 45%-fat
fed mice (for 2 weeks) relative to controls was also reported
previously (Arnold et al., 2014). This synaptic dysfunction might
be an important contributor for the hippocampal-dependent
spatial memory impairment that was measured through the
reduced spontaneous alternation in the Y-maze. In the cortex,
only the levels of gephyrin were reduced in 60% fat fed
mice versus controls, suggesting reduced inhibitory tone by
the GABAergic system. In the hypothalamus, only vesicular
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neurotransmitter transporters and not the remaining
measured synaptic proteins were reduced by HFD exposure,
suggesting reduced neurotransmission capacity in both
orexigenic and anorexigenic neurons (Meister, 2007;
Moraes et al., 2009).
CONCLUSION
In sum, increasing the dietary amount of lard-based fat
from 10 to 45% or 60% of the total energy intake leads
to obesity accompanied by increased fasting blood glucose
and insulin (pointing toward reduced insulin sensitivity),
reduced glucose tolerance and increased plasma leptin.
However, compared to controls (10%-fat) increased fed
glycemia and plasma corticosterone were only observed in
the 60%-fat fed mice. Exposure to both 45%-fat and 60%-
fat diets resulted in deterioration of systems involved in
neuro- and gliotransmission in the hippocampus, and in
impaired spatial memory performance. Metabolic alterations
measured by 1H MRS were generally observed in mice
exposed to 60%-fat but not 45%-fat diet. Therefore, we
conclude that different features of the metabolic syndrome
result in distinct neurochemical alterations in the brain,
all likely contributing for memory impairment. Moreover,
chronically increased blood glucose and/or corticosterone
appear to be main drivers for changes in brain metabolite
levels.
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